201 related articles for article (PubMed ID: 30755810)
1. microRNA-758 inhibits the malignant phenotype of osteosarcoma cells by directly targeting
Ren J; Yang M; Xu F; Chen J
Am J Cancer Res; 2019; 9(1):36-52. PubMed ID: 30755810
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma.
Xue Y; Guo Y; Liu N; Meng X
Bioengineered; 2022 Apr; 13(4):9135-9147. PubMed ID: 34753394
[TBL] [Abstract][Full Text] [Related]
4. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
6. miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1.
Liu J; Mi B; Wang Y; Shi C; Mi X; Lu Y; Yu P
Oncol Lett; 2018 Jun; 15(6):8303-8310. PubMed ID: 29928320
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-939 Directly Targets
Situ J; Zhang H; Jin Z; Li K; Mao Y; Huang W
Onco Targets Ther; 2020; 13():4257-4270. PubMed ID: 32547060
[TBL] [Abstract][Full Text] [Related]
8. miR-429 inhibits osteosarcoma progression by targeting HOXA9 through suppressing Wnt/β-catenin signaling pathway.
Sun L; Wang L; Luan S; Jiang Y; Wang Q
Oncol Lett; 2020 Sep; 20(3):2447-2455. PubMed ID: 32782562
[TBL] [Abstract][Full Text] [Related]
9. LncRNA UCA1 accelerates osteosarcoma progression via miR-145 and Wnt/β-catenin pathway.
Guan J; He J; Liao S; Wu Z; Lin X; Liu B; Qin X; Tan J; Huang C; Yuan Z; Mo H
Am J Transl Res; 2022; 14(9):6029-6042. PubMed ID: 36247254
[TBL] [Abstract][Full Text] [Related]
10. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
Yang G; Zhang C; Wang N; Chen J
Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
12. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-26a induces osteosarcoma cell growth and metastasis via the Wnt/β-catenin pathway.
Qu F; Li CB; Yuan BT; Qi W; Li HL; Shen XZ; Zhao G; Wang JT; Liu YJ
Oncol Lett; 2016 Feb; 11(2):1592-1596. PubMed ID: 26893786
[TBL] [Abstract][Full Text] [Related]
14. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway.
Lv Z; Ma J; Wang J; Lu J
Onco Targets Ther; 2019; 12():8501-8513. PubMed ID: 31686864
[TBL] [Abstract][Full Text] [Related]
16. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway.
Wang S; Du S; Lv Y; Zhang F; Wang W
Cancer Manag Res; 2019; 11():3111-3123. PubMed ID: 31114354
[No Abstract] [Full Text] [Related]
18. MicroRNA-618 Directly Targets Metadherin mRNA To Suppress The Malignant Phenotype Of Osteosarcoma Cells By Reducing PTEN-AKT Pathway Output.
Li B; Zhao J; Zhao Q; Wu D; Zhang C; Zhao K; Song Y; Gao C
Onco Targets Ther; 2019; 12():9795-9807. PubMed ID: 31814737
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-195 inhibits proliferation and metastasis in renal cell carcinoma via regulating HMGA1.
Dong H; Sun S; Yan T; Liang C; Zhu J; Miao C; Qin C; Shao P; Wang Z; Li J; Li P
Am J Transl Res; 2020; 12(6):2781-2792. PubMed ID: 32655809
[TBL] [Abstract][Full Text] [Related]
20. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
